CorMedix Inc.
CRMDNasdaqCIK 1410098HealthcareFiscal year ends Dec 31
Reports and events: 411 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1912:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-110477 |
| 2026-08-1312:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001410098-26-000056 |
| 2026-08-1311:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001410098-26-000054 |
| 2026-08-0720:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001410098-26-000044 |
| 2026-07-0220:30 ET | 8-K | 8.01 Other events | 0001410098-26-000040 |
| 2026-07-0111:14 ET | 8-K | 4.01 Change of auditor | 0001410098-26-000037 |
| 2026-06-2420:30 ET | 8-K | 5.07 Shareholder vote results | 0001410098-26-000028 |
| 2026-06-0812:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-066061 |
| 2026-05-1412:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001410098-26-000021 |
| 2026-05-1411:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001410098-26-000020 |
| 2026-04-2920:16 ET | DEF 14A | Proxy statementPeriod 2026-06-23 | 0001213900-26-049311 |
| 2026-04-2712:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-047748 |
| 2026-03-0622:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-024777 |
| 2026-03-0513:32 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-023889 |
| 2026-03-0512:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-023881 |
| 2026-01-0813:15 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-002350 |
| 2025-11-1213:21 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-108777 |
| 2025-11-1212:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-108716 |
| 2025-10-2412:21 ET | DEF 14A | Proxy statementPeriod 2025-11-10 | 0001213900-25-101906 |
| 2025-10-2012:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-100156 |
| 2025-09-3020:30 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001213900-25-093983 |
| 2025-09-0212:57 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-082956 |
| 2025-08-1220:43 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-075010 |
| 2025-08-0712:51 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-072843 |
| 2025-08-0711:31 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-072814 |
| 2025-06-3020:44 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-059702 |
| 2025-06-2510:07 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-057451 |
| 2025-06-2311:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-056415 |
| 2025-05-0612:32 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-039908 |
| 2025-05-0611:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-039903 |
| 2025-04-2820:30 ET | DEF 14A | Proxy statementPeriod 2025-06-24 | 0001213900-25-036108 |
| 2025-04-2220:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-034219 |
| 2025-04-0812:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-029629 |
| 2025-03-2512:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001013762-25-001852 |
| 2025-03-2512:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001013762-25-001844 |
| 2025-01-0713:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-001392 |
| 2024-11-2521:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-24-102170 |
| 2024-10-3012:20 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-091961 |
| 2024-10-3012:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-091959 |
| 2024-10-0820:56 ET | DEF 14A | Proxy statementPeriod 2024-11-21 | 0001213900-24-086301 |
| 2024-08-1412:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-068600 |
| 2024-08-1412:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-068589 |
| 2024-05-0912:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-041031 |
| 2024-05-0911:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-041026 |
| 2024-03-1212:15 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-021585 |
| 2024-03-1211:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-021573 |
| 2024-01-3022:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-008015 |
| 2023-12-1513:39 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-23-095909 |
| 2023-11-1621:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-087921 |
| 2023-11-1421:20 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-086981 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.